Jin Litai: the prices of various types of cathodic electrophoretic paint products rise by 10% - 20%
Financial Associated Press, August 18 - Jin Litai announced that since September 1, 2021, the prices of various types of cathodic electrophoretic paint products of the company will rise by 10% - 20%, which shall be subject to the official quotation of the company.
This text is a result of machine translation.
Related companies：
Briefing Apr 02, 2025 04:00 PM
Temu Officially Launched Its Semi-managed Business to the Malaysian Site
Briefing Mar 21, 2025 05:14 PM
· Technology
Shanghai to Launch Its First Direct Passenger Flight Route to a Central Asian Country in May
In-depth
Financials, Communication
Chinese Education Goes Global: Capturing a Trillion-Dollar Market
A TikTok filter challenge called "Mandarin Fruit Voices" has gone viral. Essentially a straightforward Mandarin learning game with crude animations, minimalist gameplay, and fruit-based pronunciation exercises drawn from early childhood education materials, it has nonetheless captivated international users. For those who once struggled with English, the long-held dream of a world united by Chinese now appears increasingly within reach.
Mar 27, 2025 06:55 PM
Briefing Feb 12, 2025 11:15 AM
U.S. President Donald Trump will Send Treasury Secretary to Ukraine
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
May 11, 2023 05:07 PM
Jan 06, 2023 08:30 AM
Briefing Oct 20, 2023 06:03 PM
· Technology
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Briefing Oct 18, 2023 07:02 PM
UAE Bets Big on Renewable Energy, Expects to Invest Over USD 160 Billion in Next 30 Years
Briefing Oct 18, 2023 07:01 PM
Wind Power is Propelled into a New Phase of Extraordinary Growth
Briefing Oct 08, 2023 06:27 PM
Shenzhen Sets Ambitious Goals for Green and Innovative Industries: Aiming for CNY 100 Billion in New Energy Industry Value
Briefing Oct 08, 2023 06:20 PM
Shenzhen Targets 1 Million Kilowatts of Virtual Power Plant Load Regulation by 2025
Briefing Oct 08, 2023 06:15 PM
Shenzhen Accelerates Drive Towards Green Construction: Over 100 Projects to Join Smart Construction Pilot by 2025
Healthcare
CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM
There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?
Apr 27, 2022 09:45 PM
Briefing Apr 19, 2022 07:44 AM
· Healthcare
China biopharmaceutical: the fifth indication of anti-tumor drug "arotinib hydrochloride capsule" has been approved
See more
Read next
Insight
In-depth
Automotive · Analysis
Chinese Automakers Break into a €10 Billion Market in Europe
Apr 11, 2025 09:57 PM
Insight
In-depth
Automotive · Analysis
Tariff Escalation Through the Lens of Geopolitical Economy
Apr 11, 2025 12:32 PM
Insight
In-depth
Consumer Staples · Analysis
China’s “Dark Cuisine” and Southeast Asia’s Wealth Code
Apr 07, 2025 03:46 PM
Insight
In-depth